Abstract
Background: Before 1983 we routinely used subxiphoid drainage for the management of pericardial effusions. Pericardial-pleural window through a left anterior thoracotomy was used in selected patients. Due to frustration over the rate of recurrent pericardial effusions with subxiphoid drainage alone and concern over the higher morbidity with thoracotomy, the creation of a 3-cm pericardial-peritoneal window in the fused portion of the pericardium and diaphragm overlying the left lobe of the liver was added to subxiphoid drainage in 1983.
Methods: This study is a retrospective chart review of the 33 patients undergoing pericardial-peritoneal window from 1983 through 1993. Eighteen patients had malignancies, mainly lung and breast, and 15 had benign pericardial effusions.
Results: The procedure was well tolerated, with a 30-day mortality of 9%; however, no deaths were directly related to the pericardial effusion or the procedure. No patient developed peritoneal carcinomatosis or diaphragmatic hernia. One patient developed recurrent pericardial effusion during follow-up, and two required pericardiectomy for constrictive disease. Among those with malignancies, patients with breast cancer had the longest survival after pericardial-peritoneal window.
Conclusions: Pericardial-peritoneal window is a simple, safe, and effective procedure and applicable to most patients with malignant and noninfectious benign pericardial effusion, including those with tamponade.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Press OW, Livingston R. Management of malignant pericardial effusion and tamponade.JAMA 1987;257:1088–92.
Wong B, Murphy J, Chang C, Hassenein K, Dunn M. The risk of pericardiocentesis.Am J Cardiol 1979;44:1110–4.
Larrey DJ. New surgical procedure to open the pericardium in the case of fluid in its cavity.Clin Chirurg 1829;26:303.
Fontenelle LJ, Cuello L, Dooley BN. Subxiphoid pericardial window—a simple and safe method for diagnosing and treating acute and chronic pericardial effusions.J Thorac Cardiovasc Surg 1971;62:95–7.
Campbell PT, Van Trigt P, Wall TC, et al. Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy.Chest 1992;101:938–43.
Dabir R, Warren SE. Drainage of pericardial effusions using the peritoneal and pericardial window technique.Surg Gynecol Obstet 1984;159:485–6.
Prager RL, Wilson CH, Bender HW. The subxiphoid approach to pericardial disease.Ann Thorac Surg 1982;34:6–9.
Sugimoto JT, Little AJ, Ferguson MK, et al. Pericardial window: mechanisms of efficacy.Ann Thorac Surg 1990;50:442–5.
Alcan KE, Zabetakis PM, Marino ND, Franzone AJ, Michelis MF, Bruno MS. Management of acute cardiac tampanade by subxiphoid pericardiotomy.JAMA 1982;247:1143–8.
Mayer HJ. Transdiaphragmatic pericardial window: a new approach.J Cardiovasc Surg 1993;34:173–5.
Mack MD, Rodney RJ, Landreneau J, Hazelrigg SR, Acuff TE. Video thoracoscopic management of benign and malignant pericardial effusions.Chest 1993;103:390S-3S.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Olson, J.E., Ryan, M.B. & Blumenstock, D.A. Eleven years' experience with pericardial-peritoneal window in the management of malignant and benign pericardial effusions. Annals of Surgical Oncology 2, 165–169 (1995). https://doi.org/10.1007/BF02303633
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02303633